返回 Agenda
Session 8, Track B: Statistical, Modeling and Dose Optimization Considerations for Trial Design
Session Chair(s)
Oxana Iliach, PhD
Senior Director Regulatory Strategy
Certara, Canada
Katalin Bertenyi
Manager, Centre for Blood, Blood Products and Biotherapeutics
Health Canada, Canada
Session 8, Track B: Statistical, Modeling and Dose Optimization Considerations for Trial Design